A patient with acute renal failure and gram-negative septicemia developed hypoprothrombinemia during treatment with cefoperazone. The coagulation defect was corrected by vitamin K administration. A multifactorial pathogenetic mechanism of vitamin K deficiency that developed during treatment with parenteral antibiotics is presented.
PineoGFGallusASHirschJ. Unexpected vitamin K deficiency in hospitalized patients. Can Med Assoc J1973; 109: 880–3.
2.
YudisMMahoodWHMarwellR. Bleeding problems with carbenicillin (letter). Lancet1972; 2: 599.
3.
LernerPILubinA. Coagulopathy with cefazolin in uremia (letter). N Engl J Med1974; 290: 1324.
4.
HooperCAHaneyBBStoneHH. Gastrointestinal bleeding due to vitamin K deficiency in patients on parenteral cefamandole. Lancet1980; 1: 39–40.
5.
RymerWGreenlawCW. Hypoprothrombinemia associated with cefamandole. Drug Intell Clin Pharm1980; 14: 780–3.
6.
HoltRJGorrochateguiMPerezC. Hypoprothrombinemia associated with moxalactam treatment of a septic sternoclavicular arthritis due toCitrobacter diversus. Drug Intell Clin Pharm1981; 15: 288–9.
7.
AndrassyKWeisschedelEHöfflerDRitzE. Führen Ureido-Penicilline zu hämostasestörungen und hämorrhagischer kolitis? (abstract)Therapiewoche1980; 30: 2777.
8.
ReedyJBaileyRR. Vitamin K deficiency developing in patients with renal failure treated with cephalosporin antibiotics. NZ Med J1980; 92: 378–80.
9.
WelchDFMatsenJM. Bactericidal activity of cefoperazone in comparison with other beta-lactam antibiotics and gentamicin. Clin Ther1980; 3(special issue): 127–9.
10.
MitsuhashiSMinamiSMatsubaraNIn vitro and in vivo antibacterial activity of cefoperazone. Clin Ther1980; 3 (special issue) 1–13.
ShimizuK. Cefoperazone: Absorption, excretion, distribution and metabolism. Clin Ther1980; 3 (special issue): 60–79.
13.
LewisJHZuckerMBFergusonJH. Bleeding tendency in uremia. Blood1956; 11: 1073–6.
14.
RabinerSF. Bleeding in uremia. Med Clin North Am1972; 56: 221–33.
15.
RemuzziGMarchesiDLivioMProstaglandins, plasma factors, and hemostasis in uremia. In: RemuzziGMeccaGde GaetanoG, eds. Hemostasis, prostaglandins, and renal disease. New York: Raven Press, 1980: 273–81.
16.
RemuzziGLivioMMeccaGde GaetanoGDonatiMB. Prostacyclin and kidney disease: Focus on uremia and thrombotic microangiopathy. In: LewisPJO'GradyJ, eds. Clinical pharmacology of prostacyclin. New York: Raven Press, 1981: 63–71.
17.
HamJM. Hypoprothrombinemia in patients undergoing prolonged intensive care. Med J Aust1971; 2: 716–8.
18.
PakterRLRussellTRMielkeHWestD. Coagulopathy associated with the use of moxalactam. JAMA1982; 248: 1100.
19.
WeitekampMRAberRC. Prolonged bleeding times and bleeding diathesis associated with moxalactam administration. JAMA1983; 249: 69–71.
20.
HooperCAHaneyBBStoneHH. Gastrointestinal bleeding due to vitamin K deficiency in patients on parenteral cefamandole. Lancet1980; 1: 39–40.
21.
RymerWGreenlawCW. Hypoprothrombinemia associated with cefamandole. Drug Intell Clin Pharm1980; 14: 780–3.
22.
AndrassyKKoderischJRitzE. Influence of cefotaxime, cefoperazone, and moxalactam on hemostasis. 22nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Oct., 1982, Miami Beach, FL (Abstract 523).
